SCHEMBL7409642

SCHEMBL7409642

O=c1[nH]c2c(n3ccnc13)Cc1c(-c3ccccc3)cccc1-2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7418354 0.84
SCHEMBL8315428 0.84
SCHEMBL7414575 0.84
SCHEMBL8553676 0.84
SCHEMBL7412874 0.84
SCHEMBL4705129 0.82
SCHEMBL7846537 0.82
Hydrochloric Acid SCHEMBL8100137 0.80
SCHEMBL7408440 0.80
SCHEMBL7846810 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2002539162-A 2002-11-19 JP claimed
EP-1161238-A1 AMYOTROPIC LATERAL SCLEROSIS TREATMENT WITH A COMBINATION OF RILUZOLE AND AN AMPA RECEPTOR ANTAGONIST Aventis Pharma S.A. (FR) 2001-12-12 EP claimed
WO-2000054772-A1 AMYOTROPIC LATERAL SCLEROSIS TREATMENT WITH A COMBINATION OF RILUZOLE AND AN AMPA RECEPTOR ANTAGONIST AVENTIS PHARMA S.A. (FR) 2000-09-21 WO claimed
EP-1161238-A1 AMYOTROPIC LATERAL SCLEROSIS TREATMENT WITH A COMBINATION OF RILUZOLE AND AN AMPA RECEPTOR ANTAGONIST Aventis Pharma S.A. (FR) 2001-12-12 EP disclosed
WO-2000054772-A1 AMYOTROPIC LATERAL SCLEROSIS TREATMENT WITH A COMBINATION OF RILUZOLE AND AN AMPA RECEPTOR ANTAGONIST AVENTIS PHARMA S.A. (FR) 2000-09-21 WO disclosed
EP-0662971-B1 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF AND MEDICAMENTS CONTAINING THEM RHONE POULENC RORER SA (FR) 1998-05-13 EP disclosed